- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
Vaxart, Inc.
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet …
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Vaxart, Inc.
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
Owner | Shares | Equivalence - $0.74 per share | Last Form/Filing | Last Transaction |
---|---|---|---|---|
10% Holder | ||||
- No data - | ||||
Officers/Directors Below 10% | ||||
Internal : Chief Financial Officer
|
113,750 | $84,175.00 |
A
45,000 x $0 =
$0
|
|
Internal : Director
|
58,125 | $43,012.50 |
A
16,000 x $0 =
$0
|
|
Internal : Director
|
30,750 | $22,755.00 |
A
16,000 x $0 =
$0
|
|
Internal : Director
|
670,840 | $496,421.60 |
A
7,375 x $0 =
$0
|
|
Internal : Director
|
24,566 | $18,178.84 |
A
6,922 x $0 =
$0
|
|
Internal : Director
|
19,115 | $14,145.10 |
G
18,240 x $0 =
$0
|
|
Internal : SVP, Chief Scientific Officer
|
355,695 | $263,214.30 |
F
3,902 x $1.30 =
$5,072.60
|
|
Internal : Chief Medical Officer
|
43,750 | $32,375.00 |
A
43,750 x $0 =
$0
|
|
Internal : SVP, General Counsel
|
45,000 | $33,300.00 |
A
45,000 x $0 =
$0
|
|
Internal : President, Chief Exec Officer
|
250,000 | $185,000.00 |
A
250,000 x $0 =
$0
|
|
Internal : President, Chief Exec Officer
|
185,000 | $136,900.00 |
A
100,000 x $0 =
$0
|
|
Internal : Director
|
125,905 | $93,169.70 |
A
7,375 x $0 =
$0
|
|
Internal : Director
|
6,217 | $4,600.58 |
A
6,217 x $0 =
$0
|
|
Internal : Interim CFO
|
0 | $0 |
|
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of Vaxart, Inc.
Short
We source Fail-To-Deliver data every month, directly from the SEC.